Atlas Trials

Clinical Study of Partially Hydrolysed Protein Infant Formula on Trans-epidermal Water Loss (TEWL)

Clinical trial NCT04763512 · COMPLETED

Trial details

NCT number
NCT04763512
Sponsor
Société des Produits Nestlé (SPN)
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Atopic DermatitisSkin Condition
Start date
2021-06-06
Primary completion
2023-09-19
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.